NAYA: Volume dana dhuwit perusahaan NAYA Biosciences Inc.

NAYA (NAYA Biosciences Inc.) - tandha merek perusahaan

NAYA Biosciences automates the development of cancer antibodies using AI and robotics, creating a defensive asset independent of macroeconomic trends. The company's cash position demonstrates financial stability, with the figure standing at 0.00. Management is focused on capital raising and scientific breakthroughs to capitalize on its innovative treatment platform.

Cadangan dhuwit perusahaan: NAYA Bio (NAYA) kanggo 04.07.2022 - 28.04.2025

Rincian metrik lan analitis perusahaan NAYA Biosciences Inc. (NAYA)

Analisis dhasar perusahaan:NAYA Biosciences Inc
Produk merek nayabiosciences.com

For NAYA Biosciences, the company's cash dynamics reflect the viability of the venture model for developing oncology assets. This indicator aggregates all highly liquid funds and equivalents available for operational management. The metric measures the business's margin of safety, allowing for the calculation of the burn rate until the next funding round. Amidst the formation of the management structure, this reserve is critical for completing early-stage clinical trials. Liquidity here serves as the primary guarantee of the company's survival in the absence of stable revenue.

Pesaing NAYA Biosciences (NAYA)

Volume dana dhuwit perusahaan ONC|HALO - Cadangan dhuwit perusahaan|Revolution Medicines - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Ascentage Pharma AAPG|CGON - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan URGN|BCAX: Volume dana dhuwit perusahaan|PSNL - Aset likuid perusahaan|ERAS (Erasca Inc) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Delcath Systems Inc DCTH|Dana dhuwit perusahaan YmAbs (YMAB)|Aset likuid perusahaan Aura Bio|Volume dana dhuwit perusahaan CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Cadangan dhuwit perusahaan|SELLAS Life Sciences Group - Volume dana dhuwit perusahaan|ACTU - Volume dana dhuwit perusahaan|CTOR: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan TuHURA (HURA)|TARA (Protara Therapeutics Inc) - Volume dana dhuwit perusahaan|Fate Therapeutics, Inc. (FATE) - Aset likuid perusahaan|Dhuwit awis perusahaan WHWK (Aadi Bioscience, Inc.)|Aset likuid perusahaan TScan Therapeutics, Inc.|Volume dana dhuwit perusahaan CSBR (Champions Oncology Corp)|Gunggung dana dhuwit perusahaan XBIT (XBiotech USA)|CVM - Dana dhuwit perusahaan|Sisa dhuwit perusahaan OSTX (ostherapies.com)|Radiopharm Theranostics Ltd (RADX) - Dana dhuwit perusahaan|ARTV: Gunggung dana dhuwit perusahaan|ANL (adlainortye.com) - Volume dana dhuwit perusahaan|VERU: Sisa dhuwit perusahaan|Dhuwit awis perusahaan TPST (Tempest Tx)|Dhuwit awis perusahaan Xilio XLO|Volume dana dhuwit perusahaan RENB (Renovaro)|Volume dana dhuwit perusahaan Mural Bio MURA|Kairos Pharma Ltd - Volume dana dhuwit perusahaan|OnKure Therapeutics (OKUR) - Dhuwit awis perusahaan|GDTC: Volume dana dhuwit perusahaan|Curis Inc. - Sisa dhuwit perusahaan|Dana dhuwit perusahaan apollomicsinc.com|THAR: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Advanced Biomed Corp (ADVB)|GNPX (Genprex, Inc) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan CLDI (Calidi Biotherapeutics)|sunshinebiopharma.com (SBFM) - Cadangan dhuwit perusahaan|Xenetic Bio - Volume dana dhuwit perusahaan|SLRX (Salarius Pharmaceuticals, Inc.) - Dhuwit awis lan setara dhuwit awis perusahaan|PPBT: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan American Oncology Network Inc|BGNE (beigene.com) - Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan CKPT (Checkpoint Therapeutics)|Dhuwit awis perusahaan ELEV (Elevation Oncology Inc.)|iCAD - Dhuwit awis lan setara dhuwit awis perusahaan|Ikena Oncology Inc. - Dhuwit awis perusahaan|Notable Labs Corp (NTBL) - Cadangan dhuwit perusahaan|VIRX: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan morphosys.com|Ascentage Pharma (AAPGV) - Dana dhuwit perusahaan